Expression of Hepatocyte Hepatitis B Core Antigen and Hepatitis B Surface Antigen as a Marker in the Management of Chronic Hepatitis B Patients
Background/Aims: We aimed to clarify the association of hepatitis B surface antigen (HBsAg)/hepatitis B core antigen (HBcAg) with the disease status and treatment response in patients with chronic hepatitis B (CHB). Methods: We investigated 171 biopsy-proven entecavir-treated CHB patients (109 hepat...
Gespeichert in:
| Veröffentlicht in: | Gut and liver 2017-05, Vol.11 (3), p.417 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | kor |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | 3 |
| container_start_page | 417 |
| container_title | Gut and liver |
| container_volume | 11 |
| creator | Sun Young Yim Tae Hyung Kim Suh Sang Jun Eun Sun Kim Bora Keum Yeon Seok Seo Hyung Joon Yim Yoon Tae Jeen Hoon Jai Chun Hong Sik Lee Soon Ho Um Chang Duck Kim Nam Hee Won Ho S |
| description | Background/Aims: We aimed to clarify the association of hepatitis B surface antigen (HBsAg)/hepatitis B core antigen (HBcAg) with the disease status and treatment response in patients with chronic hepatitis B (CHB). Methods: We investigated 171 biopsy-proven entecavir-treated CHB patients (109 hepatitis B e antigen [HBeAg]-positive, 62 HBeAg-negative). HBcAg expression was positive when ≥10% of hepatocytes stained, and classified into nuclear, mixed, and cytoplasmic patterns. HBsAg expressions were intracytoplasmic (diffuse, globular, and submembranous) and membranous. The histologic activity index (HAI) and fibrosis stage followed Ishak system. Results: In HBeAg-positive patients, older age, increased HAI score, advanced fibrosis, and reduced viral load were observed when HBcAg expression shifted from nucleus to cytoplasm in HBcAg-positive patients, and HBsAg expression from non-submembranous to submembranous in HBcAg-negative patients (all, p |
| format | Article |
| fullrecord | <record><control><sourceid>kiss</sourceid><recordid>TN_cdi_kiss_primary_3518825</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><kiss_id>3518825</kiss_id><sourcerecordid>3518825</sourcerecordid><originalsourceid>FETCH-kiss_primary_35188253</originalsourceid><addsrcrecordid>eNp9jcsKgkAYhWdRkF2eoM3_AoIXvLQsMdwEQe1lsF-dzBmZf4J8il45oxa5aXW-wwfnTJjlbqLQ9rzYn7E50dVxQteLAos900enkUgoCaqEDDtuVNEb_KAwgmAHidIIW2lEhRK4vIzk6a5LXvx4Ag4HrhvUICSYGocmeYUtSvM-SWqtpChGI8eBBk1LNi35jXD1zQVb79NzktmNIMo7LVqu-9wP3Dj2Av-_fQGnkE5z</addsrcrecordid><sourcetype>Publisher</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Expression of Hepatocyte Hepatitis B Core Antigen and Hepatitis B Surface Antigen as a Marker in the Management of Chronic Hepatitis B Patients</title><source>DOAJ Directory of Open Access Journals</source><source>KoreaMed Open Access</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Sun Young Yim ; Tae Hyung Kim ; Suh Sang Jun ; Eun Sun Kim ; Bora Keum ; Yeon Seok Seo ; Hyung Joon Yim ; Yoon Tae Jeen ; Hoon Jai Chun ; Hong Sik Lee ; Soon Ho Um ; Chang Duck Kim ; Nam Hee Won ; Ho S</creator><creatorcontrib>Sun Young Yim ; Tae Hyung Kim ; Suh Sang Jun ; Eun Sun Kim ; Bora Keum ; Yeon Seok Seo ; Hyung Joon Yim ; Yoon Tae Jeen ; Hoon Jai Chun ; Hong Sik Lee ; Soon Ho Um ; Chang Duck Kim ; Nam Hee Won ; Ho S</creatorcontrib><description>Background/Aims: We aimed to clarify the association of hepatitis B surface antigen (HBsAg)/hepatitis B core antigen (HBcAg) with the disease status and treatment response in patients with chronic hepatitis B (CHB). Methods: We investigated 171 biopsy-proven entecavir-treated CHB patients (109 hepatitis B e antigen [HBeAg]-positive, 62 HBeAg-negative). HBcAg expression was positive when ≥10% of hepatocytes stained, and classified into nuclear, mixed, and cytoplasmic patterns. HBsAg expressions were intracytoplasmic (diffuse, globular, and submembranous) and membranous. The histologic activity index (HAI) and fibrosis stage followed Ishak system. Results: In HBeAg-positive patients, older age, increased HAI score, advanced fibrosis, and reduced viral load were observed when HBcAg expression shifted from nucleus to cytoplasm in HBcAg-positive patients, and HBsAg expression from non-submembranous to submembranous in HBcAg-negative patients (all, p<0.05). In HBeAg-negative patients, only intracytoplasmic HBsAg expression patterns had clinical relevance with decreased ALT levels and viremia. In HBeAg-positive patients without favorable predictors of virologic response, negative HBcAg and membranous HBsAg expression predicted greater virologic response (both, p<0.05). The probability of HBeAg seroclearance was higher in patients with increased HAI or lacking HBcAg expression (both, p<0.05). Higher serum HBsAg levels and hepatocyte HBcAg positivity were associated with reduced serum HBsAg during first and post-first year treatment, respectively (both, p<0.05). Conclusions: Hepatocyte HBcAg/HBsAg expression is a good marker for disease status and predicting treatment response. (Gut Liver 2017;11:417-425)</description><identifier>ISSN: 1976-2283</identifier><language>kor</language><publisher>대한소화기학회</publisher><subject>chronic ; Hepatitis B ; Hepatitis B core antigens ; Hepatitis B surface antigens ; Histologic activity index</subject><ispartof>Gut and liver, 2017-05, Vol.11 (3), p.417</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784</link.rule.ids></links><search><creatorcontrib>Sun Young Yim</creatorcontrib><creatorcontrib>Tae Hyung Kim</creatorcontrib><creatorcontrib>Suh Sang Jun</creatorcontrib><creatorcontrib>Eun Sun Kim</creatorcontrib><creatorcontrib>Bora Keum</creatorcontrib><creatorcontrib>Yeon Seok Seo</creatorcontrib><creatorcontrib>Hyung Joon Yim</creatorcontrib><creatorcontrib>Yoon Tae Jeen</creatorcontrib><creatorcontrib>Hoon Jai Chun</creatorcontrib><creatorcontrib>Hong Sik Lee</creatorcontrib><creatorcontrib>Soon Ho Um</creatorcontrib><creatorcontrib>Chang Duck Kim</creatorcontrib><creatorcontrib>Nam Hee Won</creatorcontrib><creatorcontrib>Ho S</creatorcontrib><title>Expression of Hepatocyte Hepatitis B Core Antigen and Hepatitis B Surface Antigen as a Marker in the Management of Chronic Hepatitis B Patients</title><title>Gut and liver</title><addtitle>Gut and Liver</addtitle><description>Background/Aims: We aimed to clarify the association of hepatitis B surface antigen (HBsAg)/hepatitis B core antigen (HBcAg) with the disease status and treatment response in patients with chronic hepatitis B (CHB). Methods: We investigated 171 biopsy-proven entecavir-treated CHB patients (109 hepatitis B e antigen [HBeAg]-positive, 62 HBeAg-negative). HBcAg expression was positive when ≥10% of hepatocytes stained, and classified into nuclear, mixed, and cytoplasmic patterns. HBsAg expressions were intracytoplasmic (diffuse, globular, and submembranous) and membranous. The histologic activity index (HAI) and fibrosis stage followed Ishak system. Results: In HBeAg-positive patients, older age, increased HAI score, advanced fibrosis, and reduced viral load were observed when HBcAg expression shifted from nucleus to cytoplasm in HBcAg-positive patients, and HBsAg expression from non-submembranous to submembranous in HBcAg-negative patients (all, p<0.05). In HBeAg-negative patients, only intracytoplasmic HBsAg expression patterns had clinical relevance with decreased ALT levels and viremia. In HBeAg-positive patients without favorable predictors of virologic response, negative HBcAg and membranous HBsAg expression predicted greater virologic response (both, p<0.05). The probability of HBeAg seroclearance was higher in patients with increased HAI or lacking HBcAg expression (both, p<0.05). Higher serum HBsAg levels and hepatocyte HBcAg positivity were associated with reduced serum HBsAg during first and post-first year treatment, respectively (both, p<0.05). Conclusions: Hepatocyte HBcAg/HBsAg expression is a good marker for disease status and predicting treatment response. (Gut Liver 2017;11:417-425)</description><subject>chronic</subject><subject>Hepatitis B</subject><subject>Hepatitis B core antigens</subject><subject>Hepatitis B surface antigens</subject><subject>Histologic activity index</subject><issn>1976-2283</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNp9jcsKgkAYhWdRkF2eoM3_AoIXvLQsMdwEQe1lsF-dzBmZf4J8il45oxa5aXW-wwfnTJjlbqLQ9rzYn7E50dVxQteLAos900enkUgoCaqEDDtuVNEb_KAwgmAHidIIW2lEhRK4vIzk6a5LXvx4Ag4HrhvUICSYGocmeYUtSvM-SWqtpChGI8eBBk1LNi35jXD1zQVb79NzktmNIMo7LVqu-9wP3Dj2Av-_fQGnkE5z</recordid><startdate>20170530</startdate><enddate>20170530</enddate><creator>Sun Young Yim</creator><creator>Tae Hyung Kim</creator><creator>Suh Sang Jun</creator><creator>Eun Sun Kim</creator><creator>Bora Keum</creator><creator>Yeon Seok Seo</creator><creator>Hyung Joon Yim</creator><creator>Yoon Tae Jeen</creator><creator>Hoon Jai Chun</creator><creator>Hong Sik Lee</creator><creator>Soon Ho Um</creator><creator>Chang Duck Kim</creator><creator>Nam Hee Won</creator><creator>Ho S</creator><general>대한소화기학회</general><scope>HZB</scope><scope>Q5X</scope></search><sort><creationdate>20170530</creationdate><title>Expression of Hepatocyte Hepatitis B Core Antigen and Hepatitis B Surface Antigen as a Marker in the Management of Chronic Hepatitis B Patients</title><author>Sun Young Yim ; Tae Hyung Kim ; Suh Sang Jun ; Eun Sun Kim ; Bora Keum ; Yeon Seok Seo ; Hyung Joon Yim ; Yoon Tae Jeen ; Hoon Jai Chun ; Hong Sik Lee ; Soon Ho Um ; Chang Duck Kim ; Nam Hee Won ; Ho S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-kiss_primary_35188253</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>kor</language><creationdate>2017</creationdate><topic>chronic</topic><topic>Hepatitis B</topic><topic>Hepatitis B core antigens</topic><topic>Hepatitis B surface antigens</topic><topic>Histologic activity index</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sun Young Yim</creatorcontrib><creatorcontrib>Tae Hyung Kim</creatorcontrib><creatorcontrib>Suh Sang Jun</creatorcontrib><creatorcontrib>Eun Sun Kim</creatorcontrib><creatorcontrib>Bora Keum</creatorcontrib><creatorcontrib>Yeon Seok Seo</creatorcontrib><creatorcontrib>Hyung Joon Yim</creatorcontrib><creatorcontrib>Yoon Tae Jeen</creatorcontrib><creatorcontrib>Hoon Jai Chun</creatorcontrib><creatorcontrib>Hong Sik Lee</creatorcontrib><creatorcontrib>Soon Ho Um</creatorcontrib><creatorcontrib>Chang Duck Kim</creatorcontrib><creatorcontrib>Nam Hee Won</creatorcontrib><creatorcontrib>Ho S</creatorcontrib><collection>Korean Studies Information Service System (KISS)</collection><collection>Korean Studies Information Service System (KISS) B-Type</collection><jtitle>Gut and liver</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sun Young Yim</au><au>Tae Hyung Kim</au><au>Suh Sang Jun</au><au>Eun Sun Kim</au><au>Bora Keum</au><au>Yeon Seok Seo</au><au>Hyung Joon Yim</au><au>Yoon Tae Jeen</au><au>Hoon Jai Chun</au><au>Hong Sik Lee</au><au>Soon Ho Um</au><au>Chang Duck Kim</au><au>Nam Hee Won</au><au>Ho S</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Expression of Hepatocyte Hepatitis B Core Antigen and Hepatitis B Surface Antigen as a Marker in the Management of Chronic Hepatitis B Patients</atitle><jtitle>Gut and liver</jtitle><addtitle>Gut and Liver</addtitle><date>2017-05-30</date><risdate>2017</risdate><volume>11</volume><issue>3</issue><spage>417</spage><pages>417-</pages><issn>1976-2283</issn><abstract>Background/Aims: We aimed to clarify the association of hepatitis B surface antigen (HBsAg)/hepatitis B core antigen (HBcAg) with the disease status and treatment response in patients with chronic hepatitis B (CHB). Methods: We investigated 171 biopsy-proven entecavir-treated CHB patients (109 hepatitis B e antigen [HBeAg]-positive, 62 HBeAg-negative). HBcAg expression was positive when ≥10% of hepatocytes stained, and classified into nuclear, mixed, and cytoplasmic patterns. HBsAg expressions were intracytoplasmic (diffuse, globular, and submembranous) and membranous. The histologic activity index (HAI) and fibrosis stage followed Ishak system. Results: In HBeAg-positive patients, older age, increased HAI score, advanced fibrosis, and reduced viral load were observed when HBcAg expression shifted from nucleus to cytoplasm in HBcAg-positive patients, and HBsAg expression from non-submembranous to submembranous in HBcAg-negative patients (all, p<0.05). In HBeAg-negative patients, only intracytoplasmic HBsAg expression patterns had clinical relevance with decreased ALT levels and viremia. In HBeAg-positive patients without favorable predictors of virologic response, negative HBcAg and membranous HBsAg expression predicted greater virologic response (both, p<0.05). The probability of HBeAg seroclearance was higher in patients with increased HAI or lacking HBcAg expression (both, p<0.05). Higher serum HBsAg levels and hepatocyte HBcAg positivity were associated with reduced serum HBsAg during first and post-first year treatment, respectively (both, p<0.05). Conclusions: Hepatocyte HBcAg/HBsAg expression is a good marker for disease status and predicting treatment response. (Gut Liver 2017;11:417-425)</abstract><pub>대한소화기학회</pub><tpages>9</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1976-2283 |
| ispartof | Gut and liver, 2017-05, Vol.11 (3), p.417 |
| issn | 1976-2283 |
| language | kor |
| recordid | cdi_kiss_primary_3518825 |
| source | DOAJ Directory of Open Access Journals; KoreaMed Open Access; EZB-FREE-00999 freely available EZB journals; PubMed Central |
| subjects | chronic Hepatitis B Hepatitis B core antigens Hepatitis B surface antigens Histologic activity index |
| title | Expression of Hepatocyte Hepatitis B Core Antigen and Hepatitis B Surface Antigen as a Marker in the Management of Chronic Hepatitis B Patients |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T13%3A15%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-kiss&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Expression%20of%20Hepatocyte%20Hepatitis%20B%20Core%20Antigen%20and%20Hepatitis%20B%20Surface%20Antigen%20as%20a%20Marker%20in%20the%20Management%20of%20Chronic%20Hepatitis%20B%20Patients&rft.jtitle=Gut%20and%20liver&rft.au=Sun%20Young%20Yim&rft.date=2017-05-30&rft.volume=11&rft.issue=3&rft.spage=417&rft.pages=417-&rft.issn=1976-2283&rft_id=info:doi/&rft_dat=%3Ckiss%3E3518825%3C/kiss%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_kiss_id=3518825&rfr_iscdi=true |